Liver transplantation in HBsAg-positive HBV-DNA-negative cirrhotics: Immunoprophylaxis and long-term outcome

Liver Transplantation and Surgery

Volumn 2, Issue 6, 1996, Pages 418-425

  Grazi, G L ^a   Mazziotti, A ^a   Sama, C ^a   Jovine, E ^a   Stefanini, F ^a   Paladini, R ^a   Rossi, R ^a   Cavallari, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENCE RISK; TREATMENT OUTCOME;

EID: 0029958402     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500020603     Document Type: Article

References (26)

1. 1 Consensus statement on indication for liver transplantation, Paris, June 22–23,1993. Hepatology 1994 ; 20 (1 pt 2): 63S–68S.
2. 2 Stevens L, Piper J, Emond J, Heffron T, Baker A, Broelsch C. Liver transplantation for controversial indications: Alcoholic liver disease, hepatic cancer, and viral hepatitis. Transpl Proc 1991 ; 23: 1915–1916.
3. 3 Van Thiel DH, Carr B, Iwatsuki S, Tzakis A, Fung JJ, Starzl TE. Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transpl Proc 1991 ; 23: 1917–1921.
4. 4 Starzl TE, Demetris AJ, Van Thiel DH. Liver transplantation. N Engl J Med 1989 ; 321: 1092–1099.
5. 5 Villamil FG, Vierling JM. Recurrence of viral hepatitis following liver transplantation: Insight into management. Liv Transpl Surg 1995 ; 5 (Suppl 1): 89–99.
6. 6 Demetris AJ, Jaffe R, Sheahan DG, Burnham J, Spero J, Iwatsuki S, et al. Recurrent hepatitis B in liver allograft recipients. Am J Pathol 1986 ; 125: 161–172.
7. 7 O'Grady JG, Smith HM, Davies SE, Daniels HM, Donaldson PT, Tan KC, et al. Hepatitis B virus reinfection after orthotopic liver transplantation. J Hepatol 1992 ; 14: 104–111.
8. 8 Martin P, Friedman LS. Recurrent hepatitis B in liver transplant recipients—no easy answers. Gastroenterol 1991 ; 101: 1131–1133.
9. 9 Bäckman L, Gibbs J, Levy M, McMillian R, Holman M, Husberg B, et al. Causes of late graft loss after liver transplantation. Transplantation 1993 ; 55: 1078–1082.
10. 10 Muller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, et al. Liver transplantation in Hbs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991 ; 13: 90–96.
11. 11 Samuel D, Bismuth A, Serres C, Arulnaden JL, Reynes M, Benhamou JP, et al. HBV infection after liver transplantation in HBsAg positive patients: Experience with long‐term immunoprophylaxis. Lancet 1991 ; 337: 813–815.
12. 12 Norusis MJ. SPSS/PC+ User's Guide, Version 5.0. Chicago, IL, SPSS, Inc, 1992.
13. 13 Hopkins A. Survival analysis with covariates. In: Dixon WJ, Brown MB, Engelman L, Jennrich RI (eds). BMDP statistical software. Berkeley, University of California Press, 1993 ; 769–806.
14. 14 Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993 ; 329: 1842–1847.
15. 15 Freeman RB, Sanchez H, Lewis WD, Sherburne B, Dzik WH, Khettry U, et al. Serologic and DNA follow‐up data from HBsAg‐positive patients treated with orthotopic liver transplantation. Transplantation 1991 ; 51: 793–797.
16. 16 Lauchart W, Müller R, Pichlmayr R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. Transplant Proc 1987 ; 19: 2387–2389.
17. 17 Feray C, Zignego AL, Samuel D. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection: The liver transplantation model. Transplantation 1990 ; 49: 1155–1158.
18. 18 Lake JR. Should liver transplantation be performed for patients with chronic hepatitis B? Yes! Liver Transpl Surg 1995 ; 1: 260–265.
19. 19 König V, Hopf U, Neuhaus P, Bauditz J, Schmidt CA, Blumhardt G, et al. Long term follow‐up of hepatitis B virus‐infected recipients after orthotopic liver transplantation. Transplantation 1994 ; 58: 553–559.
20. 20 Wright TL, Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transpl Surg 1995 ; 1: 30–42.
21. 21 Crippin J, Foster B, Carlen S, Borcich A, Bodenheimer H Jr., Retransplantation in hepatitis B—A multicenter experience. Transplantation 1994 ; 57: 823–826.
22. 22 Ishitani M, McGory R, Dickson R, Caldwell S, McCullough C, Stevenson W, et al. Successful retransplantation for severe post‐transplant hepatitis B virus (HBV) infection in the primary allograft. Liver Transpl Surg 1995 ; 1: 448.
23. 23 Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology 1996 ; 23: 1–7.
24. 24 Singh N, Gayowski T. Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation. Transplantation 1995 ; 59: 1629–1630.
25. 25 Flowers M, Sherker A, Sinclair SB, Greig PD, Cameron R, Phillips MJ, et al. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation. Transplantation 1994 ; 58: 183–191.
26. 26 Bartholomew M, Vicary C, Roach K, Jeffers LJ, Bernstein D, de Medina M, et al. Use of lamivudine in the treatment of recurrent hepatitis B infection post‐liver transplantation. Gastroenterology 1995 ; 108: A1030.